✦ LIBER ✦

Drug companies should not have the final say in the design of clinical trials

✍ Scribed by Neil A. Kurtzman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Trials in the Evaluation of Ant

✍ ARTHUR J. MOSS 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

Role of “health-related quality of life”

✍ R. San Miguel; V. del Villar; C. Pérez; M. de Frutos; J. Mar; M.J. Coma 📂 Article 📅 2010 🏛 Elsevier Science 🌐 Spanish ⚖ 162 KB

Clinical trials of the first candidate H

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Issues in the design and analysis of cli

✍ Thomas J. Uryniak 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Patients With Drug-Induced Microscopic C

✍ Laurent Beaugerie; Darrell S. Pardi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Net clinical benefit outcome should be s

✍ Caldeira, Daniel; Costa, João; Ferreira, Joaquim J.; Pinto, Fausto J. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 121 KB